Sunday, October 5, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Mixed Analyst Opinions on Oktas Future Performance

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
Finance_Fiscal (2)
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On February 29, 2024, analyst Michael Walkley from Canaccord Genuity has decided to uphold his Hold rating on Okta (NASDAQ: OKTA) but has increased the price target to $95, up from $85. This adjustment reflects his perspective on the stock‘s potential performance in the market.
_____
As of the same date, opinions from analysts regarding Okta have been varied. Both Canaccord Genuity and Stephens have issued Hold ratings for the company, highlighting the uncertainty surrounding its future prospects.

OKTA Stock Surges 25% on February 29, 2024: A Promising Investment Opportunity

On February 29, 2024, OKTA stock had an impressive performance, trading near the top of its 52-week range and above its 200-day simple moving average. The price of OKTA shares saw a significant increase of $22.05 since the market last closed, representing a 25.26% rise. OKTA, a cloud-based identity management company, has been gaining momentum in the market due to its innovative solutions and strong financial performance. Investors who purchased OKTA stock on February 29, 2024, saw substantial gains as the stock continued to rise throughout the day. Overall, OKTA’s stock performance on February 29, 2024, demonstrated its potential for further growth and success in the market. Investors will be closely monitoring the company’s future developments and financial results to capitalize on the opportunities presented by this high-performing stock.

OKTA Inc. Reports Strong Financial Performance in Q1 2024

OKTA Inc. (OKTA) has been making significant strides in its financial performance, as evidenced by its latest earnings report for the quarter ending on February 29, 2024. The company reported total revenue of $584.00 million for the quarter, which represents a 5.04% increase from the previous quarter and a substantial 42.9% increase from the same period last year when total revenue was $1.86 billion. In terms of net income, OKTA reported a loss of $81.00 million for the quarter, which is a significant improvement from the net loss of $815.00 million reported in the same period last year. This represents a 27.03% increase in net income from the previous quarter and a 3.94% increase from the same period last year. Furthermore, OKTA’s earnings per share (EPS) also showed positive growth, with a reported EPS of -$0.49 for the quarter, which is a 27.74% increase from the previous quarter and a 10.01% increase from the same period last year when EPS was -$5.16. Overall, OKTA’s financial performance for the quarter ending on February 29, 2024, reflects a strong growth trajectory, with significant improvements in total revenue, net income, and EPS. Investors may view these positive trends as a bullish indicator for the company’s future prospects and may consider OKTA stock as a potential investment opportunity.

Tags: OKTA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Financing and finances

BlackRock TCP Capital Corp Reports Strong Net Investment Income and Declares Steady Dividend

Entertainment stock Trading

Studio City International Holdings Limited Reports Significant Improvement in Quarterly Financial Performance

NeuroBo Pharmaceuticals Receives IRB Approval for Phase 1 Clinical Trial of DA1726 A Potential Treatment for Obesity

Recommended

Finance_Budgeting (1)

Betsy Graseck Maintains Underweight Rating on PNC Financial Services Group with Revised Price Target

2 years ago
Finance_Financing

Comprehensive Compilation of Stocks and their Returns

2 years ago
Biotechnology Market Capitalization

Tyra Biosciences Inc Secures 200 Million in Private Placement Financing

2 years ago
LVMH Stock

LVMH Shares Poised for Potential Rebound as Goldman Sachs Raisises Outlook

1 week ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

A Pivotal Week for Super League Gaming’s Strategic Trajectory

Is Medical Properties Trust Mounting a Sustainable Recovery?

Theriva Biologics Faces Critical Juncture Following Deep Workforce Cuts

Sonoma Pharmaceuticals Shares Experience Dramatic Trading Session

Fuel Cell Surge: Bloom Energy Stock Soars on Massive AI Power Project

Can Copart Stock Overcome Market Indifference?

Trending

Zscaler Stock
AI & Quantum Computing

Insider Selling Clouds Zscaler’s AI-Driven Rally

by Robert Sasse
October 5, 2025
0

As artificial intelligence continues to dominate technology sector narratives, cybersecurity firm Zscaler demonstrates tangible progress in converting...

iShares Gold Trust Stock

Gold ETF Soars as Economic Uncertainty Drives Safe-Haven Demand

October 5, 2025
Qurate Retail Stock

Qurate Retail’s Moment of Truth Approaches

October 5, 2025
Super League Gaming Inc Stock

A Pivotal Week for Super League Gaming’s Strategic Trajectory

October 5, 2025
Medical Properties Stock

Is Medical Properties Trust Mounting a Sustainable Recovery?

October 5, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Insider Selling Clouds Zscaler’s AI-Driven Rally
  • Gold ETF Soars as Economic Uncertainty Drives Safe-Haven Demand
  • Qurate Retail’s Moment of Truth Approaches

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com